Conteduca, V., Wetterskog, D., Sharabiani, M. T. A., Grande, E., Fernandez Perez, M. P., Jayaram, A., . . . Attard, G. (2017). Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study.
Citação norma ChicagoConteduca, Vincenza|||0000-0002-6921-714X, et al. Androgen Receptor Gene Status in Plasma DNA Associates With Worse Outcome On Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study. 2017.
Citação norma MLAConteduca, Vincenza|||0000-0002-6921-714X, et al. Androgen Receptor Gene Status in Plasma DNA Associates With Worse Outcome On Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study. 2017.